has decreased by 6.30% despite total hospital income from general patients increased 8.69% compared with the same period of last year. This is mainly due to the medical-service-fee adjustment caused by

the same period of last year mainly due to lower aluminium prices. However, when comparing with previous quarter, it was decreased only 1.92% 2. Cost of sales was 403.56 million Baht or 102.57% of sales

, investor contact will be able to take only the test specific to such product. The test offers 4 sections which are equity instrument, debt instrument, mutual fund and derivatives. Titles of ?Category A

only 18 days). However, income tax expenses in Q1/2020 increased as a result of the increase in deferred income tax expenses following the implementation of Thai Financial Reporting Standard regarding

4,574.73 million which increased for THB 338.95 million or 8.00% from the fiscal year 2013 which realized the revenue THB 4,235.78 million, where the reasons are summarized as follows. Unit : Million Baht

of THB 450.00 million, however, short-term loans from related persons increased in amount of THB 445.40 million. All short-term and long-term loans of the Group are in THB currency only, thus; The

could accelerate operations. As a result, the company's revenue slightly lower than those in 2 0 2 1 , only decreased by 4. 4% . Most of the company's revenue recognized in 2022 such as the Project of

material and By-product increased by Baht 1,716.30 or 469.65%, from sales of raw materials for a produce biodiesel to the customers in the same industry. However, the Company will only sell by-products that

2018 increased when compared to 2017 because there was accrued bonuses in 2018 while there was only incentives booked in the last year. Therefore, in 2018, there were both accrued bonus and incentives

increased by THB 29.8 mm or 2.8%, compared to the same period of the last year. If excluding FX impact, the normalized net profit increased by THB 312.1 mm or 38.3%. If considering only 3-month period ending